Schedule 13G ownership disclosure

ONCOCYTE CORPORATION

Security class unavailable · CUSIP: 68235C107

Event date: 2022-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,129,456
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-010223
Form type
SC 13G
Filer
Halle Special Situations Fund LLC
CIK
CIK 1849578
Filed
Apr 18, 2022
Reporting period
Apr 18, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub